T

Toyohashi Heart Center | Cardiology Department

Research site

(Unclaimed)

Location

21-1 Gobutori, Oyama,, Toyohashi, Aichi, Japan

Site insights

Top conditions

Top treatments

Vitamin K

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 12 total trials

Amplatzer Amulet LAAO Vs. NOAC (CATALYST)

The objective of this trial is to evaluate the safety and effectiveness of the Amulet LAA occluder compared to NOAC therapy in patients with non-valv...

Enrolling

Atrial Fibrillation

Stroke

Drug: Non-Vitamin K Oral Antagonists

Device: Left Atrial Appendage Occlusion (Amplatzer Amulet LAA Occluder)

CHAMPION-AF Clinical Trial

The primary objective of this study is to determine if left atrial appendage closure (LAAC) with the WATCHMAN FLX device is a reasonable alternative...

Active, not recruiting

Atrial Fibrillation

Stroke

Drug: Non-Vitamin K Oral Anticoagulant

Device: WATCHMAN FLX LAAC Device

New

Non-antithrombotic Versus. Single Antiplatelet Therapy Following Left Atrial Appendage Closure

The goal of this clinical trial is to verify that Non-Antithrombotic Therapy (NAPT) followed by Oral Anticoagulants (OAC) monotherapy for 45 days aft...

Enrolling

Left Atrial Appendage Closure

High Bleeding Risk

Drug: Single Antiplatelet Therapy or No Therapy (Control)

Other: Non-Antithrombotic Therapy